Related references
Note: Only part of the references are listed.Inflammatory Markers in Blood and Serum Tumor Markers Predict Survival in Patients With Epithelial Appendiceal Neoplasms Undergoing Surgical Cytoreduction and Intraperitoneal Chemotherapy
Terence C. Chua et al.
ANNALS OF SURGERY (2012)
Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer
Hyuk-Chan Kwon et al.
BIOMARKERS (2012)
Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer
R. Carruthers et al.
COLORECTAL DISEASE (2012)
Can neutrophil-to-lymphocyte ratio predict the survival of colorectal cancer patients who have received curative surgery electively?
Sum-Fu Chiang et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2012)
Association of Obesity With DNA Mismatch Repair Status and Clinical Outcome in Patients With Stage II or III Colon Carcinoma Participating in NCCTG and NSABP Adjuvant Chemotherapy Trials
Frank A. Sinicrope et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer
W. Chua et al.
BRITISH JOURNAL OF CANCER (2011)
An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study
M. J. Proctor et al.
BRITISH JOURNAL OF CANCER (2011)
DNA Methylation Predicts Recurrence From Resected Stage III Proximal Colon Cancer
Joong Bae Ahn et al.
CANCER (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Defective Mismatch Repair Status as a Prognostic Biomarker of Disease-Free Survival in Stage III Colon Cancer Patients Treated with Adjuvant FOLFOX Chemotherapy
Aziz Zaanan et al.
CLINICAL CANCER RESEARCH (2011)
Role of systemic inflammatory response in predicting survival in patients with primary operable cancer
Campbell S. D. Roxburgh et al.
FUTURE ONCOLOGY (2010)
IMP3 Is a Novel Prognostic Marker that Correlates with Colon Cancer Progression and Pathogenesis
Dawei Li et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
PIK3CA Mutation Is Associated With Poor Prognosis Among Patients With Curatively Resected Colon Cancer
Shuji Ogino et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Prognostic Significance of C-Reactive Protein and Smoking in Patients with Advanced Non-small Cell Lung Cancer Treated with First-Line Palliative Chemotherapy
Andrea Koch et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer
Mitsuru Ishizuka et al.
ANNALS OF SURGERY (2007)
Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer
E. F. Leitch et al.
BRITISH JOURNAL OF CANCER (2007)
Evaluation of the relationship between the systemic inflammatory response and cancer-specific survival in patients with primary operable breast cancer
A. M. Al Murri et al.
BRITISH JOURNAL OF CANCER (2007)
Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer
SR Walsh et al.
JOURNAL OF SURGICAL ONCOLOGY (2005)
Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas
NB Jamieson et al.
BRITISH JOURNAL OF CANCER (2005)
Share Paper
